| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.748 | 0.005 | 0.748 | Anticonvulsant | 0.554 0.009 CID_9785 | ||
| 0.686 | 0.004 | 0.706 | Anesthetic general | 0.706 0.003 CID_9785 | CID_9785 | |
| 0.614 | 0.017 | 0.747 | Aldehyde oxidase inhibitor | 0.747 0.005 CID_9785 | CID_9785 | |
| 0.579 | 0.003 | 0.579 | Nav1.1 sodium channel blocker | 0.506 0.004 CID_9785 | ||
| 0.563 | 0.003 | 0.563 | Lipocortins synthesis antagonist | 0.52 0.003 CID_9785 | ||
| 0.548 | 0.008 | 0.548 | Psychostimulant | 0.526 0.009 CID_9785 | ||
| 0.523 | 0.02 | 0.565 | Spasmolytic | 0.565 0.016 CID_9785 | CID_9785 | |
| 0.452 | 0.041 | 0.48 | GABA C receptor rho-3 antagonist | 0.48 0.031 CID_9785 | CID_9785 | |
| 0.456 | 0.058 | 0.456 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.335 0.168 CID_9785 | ||
| 0.401 | 0.007 | 0.401 | Nav1.2 sodium channel blocker | 0.332 0.012 CID_9785 | ||
| 0.329 | 0.005 | 0.329 | Nav1.6 sodium channel blocker | 0.261 0.008 CID_9785 | ||
| 0.348 | 0.024 | 0.378 | RNA-directed DNA polymerase inhibitor | 0.378 0.02 CID_9785 | CID_9785 | |
| 0.31 | 0.008 | 0.31 | Nav1.3 sodium channel blocker | 0.224 0.018 CID_9785 | ||
| 0.316 | 0.036 | 0.326 | Cyclic AMP phosphodiesterase inhibitor | 0.326 0.032 CID_9785 | CID_9785 | |
| 0.353 | 0.085 | 0.363 | Immunosuppressant | 0.363 0.08 CID_9785 | CID_9785 | |
| 0.313 | 0.051 | 0.313 | Cardiotonic | 0.249 0.083 CID_9785 | ||
| 0.303 | 0.042 | 0.334 | DNA synthesis inhibitor | 0.334 0.034 CID_9785 | CID_9785 | |
| 0.328 | 0.071 | 0.371 | Immunostimulant | 0.371 0.058 CID_9785 | CID_9785 | |
| 0.263 | 0.012 | 0.263 | Ferrochelatase inhibitor | 0.159 0.034 CID_9785 | ||
| 0.263 | 0.027 | 0.263 | Tumour necrosis factor antagonist | 0.255 0.029 CID_9785 | ||
| 0.289 | 0.054 | 0.361 | Superoxide dismutase inhibitor | 0.361 0.034 CID_9785 | CID_9785 | |
| 0.284 | 0.054 | 0.303 | Vasodilator | 0.303 0.047 CID_9785 | CID_9785 | |
| 0.355 | 0.141 | 0.427 | Caspase 9 stimulant | 0.427 0.095 CID_9785 | CID_9785 | |
| 0.306 | 0.094 | 0.316 | Vasodilator, peripheral | 0.316 0.089 CID_9785 | CID_9785 | |
| 0.22 | 0.01 | 0.22 | 5 Hydroxytryptamine 7 antagonist | 0.104 0.024 CID_9785 | ||
| 0.227 | 0.017 | 0.227 | GABA C receptor rho-2 antagonist | 0.218 0.021 CID_9785 | ||
| 0.27 | 0.063 | 0.27 | 5 Hydroxytryptamine uptake stimulant | 0.262 0.07 CID_9785 | ||
| 0.254 | 0.048 | 0.276 | Peptidyltransferase inhibitor | 0.276 0.035 CID_9785 | CID_9785 | |
| 0.214 | 0.01 | 0.218 | Antineoplastic alkaloid | 0.218 0.009 CID_9785 | CID_9785 | |
| 0.247 | 0.044 | 0.265 | Growth hormone agonist | 0.265 0.04 CID_9785 | CID_9785 | |
| 0.333 | 0.131 | 0.356 | 5 Hydroxytryptamine release inhibitor | 0.356 0.11 CID_9785 | CID_9785 | |
| 0.26 | 0.059 | 0.322 | Tyrosine 3 hydroxylase inhibitor | 0.322 0.024 CID_9785 | CID_9785 | |
| 0.213 | 0.014 | 0.213 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.182 0.019 CID_9785 | ||
| 0.272 | 0.079 | 0.275 | 5 Hydroxytryptamine release stimulant | 0.275 0.078 CID_9785 | CID_9785 | |
| 0.261 | 0.07 | 0.261 | Tumour necrosis factor alpha release inhibitor | 0.255 0.073 CID_9785 | ||
| 0.202 | 0.018 | 0.226 | UDP-glucose 4-epimerase inhibitor | 0.226 0.015 CID_9785 | CID_9785 | |
| 0.276 | 0.107 | 0.283 | Thyroid hormone antagonist | 0.283 0.102 CID_9785 | CID_9785 | |
| 0.276 | 0.108 | 0.284 | Vasodilator, coronary | 0.284 0.102 CID_9785 | CID_9785 | |
| 0.264 | 0.115 | 0.322 | Cholesterol antagonist | 0.322 0.078 CID_9785 | CID_9785 | |
| 0.173 | 0.026 | 0.173 | GABA receptor agonist | 0.137 0.044 CID_9785 | ||
| 0.19 | 0.048 | 0.19 | Diuretic | 0.169 0.061 CID_9785 | ||
| 0.211 | 0.071 | 0.233 | Nitric-oxide synthase stimulant | 0.233 0.046 CID_9785 | CID_9785 | |
| 0.148 | 0.008 | 0.148 | Phosphodiesterase 4C inhibitor | 0.091 0.017 CID_9785 | ||
| 0.157 | 0.018 | 0.157 | Phosphodiesterase 4D inhibitor | 0.129 0.024 CID_9785 | ||
| 0.273 | 0.14 | 0.363 | Histamine release inhibitor | 0.363 0.094 CID_9785 | CID_9785 | |
| 0.175 | 0.043 | 0.175 | Alpha-N-acetylglucosaminidase inhibitor | 0.154 0.053 CID_9785 | ||
| 0.149 | 0.019 | 0.164 | Anabolic | 0.164 0.012 CID_9785 | CID_9785 | |
| 0.232 | 0.102 | 0.232 | Gastrin inhibitor | |||
| 0.149 | 0.02 | 0.149 | Electrolyte absorption antagonist | 0.118 0.038 CID_9785 | ||
| 0.152 | 0.029 | 0.152 | GABA C receptor antagonist | 0.148 0.031 CID_9785 | ||
| 0.146 | 0.023 | 0.146 | GABA C receptor rho-1 antagonist | 0.131 0.031 CID_9785 | ||
| 0.177 | 0.058 | 0.177 | Cytidine deaminase inhibitor | 0.124 0.096 CID_9785 | ||
| 0.144 | 0.026 | 0.144 | DNA directed RNA polymerase inhibitor | 0.112 0.043 CID_9785 | ||
| 0.134 | 0.02 | 0.143 | Metalloproteinase-9 inhibitor | 0.143 0.017 CID_9785 | CID_9785 | |
| 0.146 | 0.033 | 0.168 | Bronchodilator | 0.168 0.026 CID_9785 | CID_9785 | |
| 0.221 | 0.108 | 0.221 | 5 Hydroxytryptamine 1E antagonist | 0.209 0.121 CID_9785 | ||
| 0.134 | 0.024 | 0.143 | Metalloproteinase-2 inhibitor | 0.143 0.021 CID_9785 | CID_9785 | |
| 0.279 | 0.175 | 0.4 | Calcium channel L-type activator | 0.4 0.081 CID_9785 | CID_9785 | |
| 0.163 | 0.06 | 0.219 | Protein kinase stimulant | 0.219 0.035 CID_9785 | CID_9785 | |
| 0.117 | 0.014 | 0.117 | Biliverdin reductase inhibitor | 0.09 0.022 CID_9785 | ||
| 0.142 | 0.04 | 0.142 | 5 Hydroxytryptamine 3A agonist | 0.122 0.054 CID_9785 | ||
| 0.14 | 0.038 | 0.14 | GABA C receptor agonist | 0.135 0.041 CID_9785 | ||
| 0.117 | 0.02 | 0.117 | Glycine receptor antagonist | 0.095 0.037 CID_9785 | ||
| 0.118 | 0.023 | 0.118 | HIV-1 reverse transcriptase inhibitor | 0.1 0.031 CID_9785 | ||
| 0.229 | 0.135 | 0.229 | Ca(v)3.3 blocker | |||
| 0.106 | 0.013 | 0.132 | Androgen agonist | 0.132 0.009 CID_9785 | CID_9785 | |
| 0.103 | 0.009 | 0.103 | Phosphodiesterase 1A inhibitor | 0.071 0.023 CID_9785 | ||
| 0.127 | 0.035 | 0.139 | HIV-1 integrase (Overall Integration) inhibitor | 0.139 0.029 CID_9785 | CID_9785 | |
| 0.098 | 0.006 | 0.098 | Guanylate cyclase stimulant | 0.062 0.013 CID_9785 | ||
| 0.119 | 0.027 | 0.119 | Phosphodiesterase I inhibitor | 0.109 0.035 CID_9785 | ||
| 0.128 | 0.037 | 0.128 | Acetylcholine release stimulant | 0.098 0.092 CID_9785 | ||
| 0.164 | 0.072 | 0.189 | Neurotensin receptor agonist | 0.189 0.041 CID_9785 | CID_9785 | |
| 0.133 | 0.043 | 0.136 | Photosensitizer | 0.136 0.041 CID_9785 | CID_9785 | |
| 0.1 | 0.015 | 0.123 | NMDA 2C receptor antagonist | 0.123 0.01 CID_9785 | CID_9785 | |
| 0.183 | 0.098 | 0.183 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.088 | 0.008 | 0.095 | Dihydroorotate oxidase inhibitor | 0.095 0.005 CID_9785 | CID_9785 | |
| 0.113 | 0.033 | 0.122 | NADH dehydrogenase inhibitor | 0.122 0.027 CID_9785 | CID_9785 | |
| 0.104 | 0.025 | 0.104 | Matrix metalloproteinase inhibitor | 0.104 0.025 CID_9785 | ||
| 0.08 | 0.003 | 0.08 | Nicotinic acid receptor 2 antagonist | 0.067 0.003 CID_9785 | ||
| 0.088 | 0.013 | 0.088 | MDM2 inhibitor | 0.074 0.03 CID_9785 | ||
| 0.092 | 0.018 | 0.092 | Collagenase 3 inhibitor | 0.078 0.026 CID_9785 | ||
| 0.223 | 0.148 | 0.317 | Transcription factor NF kappa B inhibitor | 0.317 0.087 CID_9785 | CID_9785 | |
| 0.163 | 0.091 | 0.175 | Succinate dehydrogenase inhibitor | 0.175 0.074 CID_9785 | CID_9785 | |
| 0.1 | 0.03 | 0.174 | Keratolytic | 0.174 0.011 CID_9785 | CID_9785 | |
| 0.091 | 0.021 | 0.091 | Phospholipase D inhibitor | 0.07 0.052 CID_9785 | ||
| 0.105 | 0.036 | 0.115 | Interleukin 5 antagonist | 0.115 0.027 CID_9785 | CID_9785 | |
| 0.077 | 0.007 | 0.103 | Nicotinic acid receptor agonist | 0.103 0.005 CID_9785 | CID_9785 | |
| 0.07 | 0.004 | 0.07 | Uridine phosphorylase inhibitor | 0.065 0.005 CID_9785 | ||
| 0.142 | 0.077 | 0.163 | Adenylate cyclase stimulant | 0.163 0.044 CID_9785 | CID_9785 | |
| 0.084 | 0.018 | 0.115 | NMDA 2A receptor antagonist | 0.115 0.01 CID_9785 | CID_9785 | |
| 0.145 | 0.08 | 0.356 | Peroxidase inhibitor | 0.356 0.027 CID_9785 | CID_9785 | |
| 0.073 | 0.01 | 0.073 | Thymidine kinase inhibitor | 0.062 0.013 CID_9785 | ||
| 0.091 | 0.027 | 0.091 | Phosphodiesterase III inhibitor | 0.085 0.032 CID_9785 | ||
| 0.089 | 0.027 | 0.089 | Neutrophil collagenase inhibitor | 0.087 0.028 CID_9785 | ||
| 0.086 | 0.023 | 0.086 | Argininosuccinate synthase inhibitor | 0.074 0.028 CID_9785 | ||
| 0.124 | 0.064 | 0.124 | DNA repair enzyme inhibitor | 0.122 0.068 CID_9785 | ||
| 0.073 | 0.013 | 0.073 | Aldosterone antagonist | 0.044 0.04 CID_9785 | ||
| 0.062 | 0.004 | 0.062 | Guanylate cyclase 1 stimulant | 0.028 0.007 CID_9785 | ||
| 0.122 | 0.065 | 0.145 | Adenylate cyclase inhibitor | 0.145 0.049 CID_9785 | CID_9785 | |
| 0.076 | 0.021 | 0.076 | Matrix metalloproteinase (membrane-type) inhibitor | 0.071 0.024 CID_9785 | ||
| 0.06 | 0.007 | 0.06 | Kainate receptor agonist | 0.058 0.008 CID_9785 | ||
| 0.074 | 0.023 | 0.074 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.063 0.032 CID_9785 | ||
| 0.107 | 0.057 | 0.107 | Adenylate kinase inhibitor | 0.098 0.071 CID_9785 | ||
| 0.109 | 0.06 | 0.143 | AMP-activated protein kinase stimulant | 0.143 0.033 CID_9785 | CID_9785 | |
| 0.06 | 0.011 | 0.071 | Nicotinic acid receptor 2 agonist | 0.071 0.009 CID_9785 | CID_9785 | |
| 0.067 | 0.018 | 0.067 | Pregnane X receptor antagonist | 0.066 0.019 CID_9785 | ||
| 0.202 | 0.154 | 0.218 | Insulysin inhibitor | 0.218 0.131 CID_9785 | CID_9785 | |
| 0.164 | 0.118 | 0.216 | Neurotrophic factor enhancer | 0.216 0.062 CID_9785 | CID_9785 | |
| 0.143 | 0.097 | 0.163 | Arachidonic acid antagonist | 0.163 0.074 CID_9785 | CID_9785 | |
| 0.099 | 0.054 | 0.104 | Phosphodiesterase 6D inhibitor | 0.104 0.045 CID_9785 | CID_9785 | |
| 0.136 | 0.091 | 0.136 | Ca2+-transporting ATPase inhibitor | 0.135 0.094 CID_9785 | ||
| 0.16 | 0.116 | 0.242 | Angiogenesis stimulant | 0.242 0.074 CID_9785 | CID_9785 | |
| 0.08 | 0.038 | 0.08 | Glycine receptor agonist | 0.08 0.039 CID_9785 | ||
| 0.133 | 0.094 | 0.133 | Sphingosine 1-phosphate receptor 5 antagonist | 0.13 0.101 CID_9785 | ||
| 0.125 | 0.086 | 0.125 | Sphingosine 1-phosphate receptor 2 antagonist | 0.125 0.086 CID_9785 | ||
| 0.042 | 0.005 | 0.042 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.035 0.007 CID_9785 | ||
| 0.125 | 0.088 | 0.224 | Lipid peroxidase inhibitor | 0.224 0.033 CID_9785 | CID_9785 | |
| 0.065 | 0.029 | 0.069 | Matrix metalloproteinase 1 inhibitor | 0.069 0.026 CID_9785 | CID_9785 | |
| 0.047 | 0.011 | 0.047 | Calcitonin gene-related peptide antagonist | |||
| 0.039 | 0.003 | 0.039 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.031 0.004 CID_9785 | ||
| 0.111 | 0.077 | 0.111 | Acetylcholine muscarinic antagonist | 0.109 0.079 CID_9785 | ||
| 0.041 | 0.006 | 0.041 | Thymidine phosphorylase inhibitor | 0.035 0.008 CID_9785 | ||
| 0.095 | 0.061 | 0.122 | Prolactin inhibitor | 0.122 0.037 CID_9785 | CID_9785 | |
| 0.052 | 0.018 | 0.052 | Parathyroid hormone antagonist | 0.044 0.035 CID_9785 | ||
| 0.219 | 0.186 | 0.219 | Calcium channel activator | |||
| 0.066 | 0.035 | 0.066 | Phosphodiesterase 1C inhibitor | 0.06 0.048 CID_9785 | ||
| 0.075 | 0.044 | 0.086 | Phosphofructokinase-1 inhibitor | 0.086 0.038 CID_9785 | CID_9785 | |
| 0.055 | 0.024 | 0.055 | Mineralocorticoid receptor antagonist | 0.047 0.035 CID_9785 | ||
| 0.036 | 0.007 | 0.036 | DNA polymerase III inhibitor | 0.031 0.013 CID_9785 | ||
| 0.053 | 0.024 | 0.053 | Adenylate cyclase 1 inhibitor | 0.048 0.029 CID_9785 | ||
| 0.084 | 0.056 | 0.108 | Estrogen-related receptor beta agonist | 0.108 0.017 CID_9785 | CID_9785 | |
| 0.091 | 0.063 | 0.13 | Alcohol dehydrogenase inhibitor | 0.13 0.029 CID_9785 | CID_9785 | |
| 0.033 | 0.007 | 0.033 | Acid ceramidase inhibitor | |||
| 0.085 | 0.06 | 0.112 | Androgen antagonist | 0.112 0.038 CID_9785 | CID_9785 | |
| 0.04 | 0.016 | 0.04 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.079 | 0.056 | 0.079 | Acetylcholine nicotinic antagonist | |||
| 0.059 | 0.036 | 0.121 | Alcohol oxidase inhibitor | 0.121 0.014 CID_9785 | CID_9785 | |
| 0.099 | 0.077 | 0.187 | Cystathionine beta-synthase inhibitor | 0.187 0.028 CID_9785 | CID_9785 | |
| 0.133 | 0.112 | 0.161 | CF transmembrane conductance regulator agonist | 0.161 0.059 CID_9785 | CID_9785 | |
| 0.09 | 0.07 | 0.09 | Alpha 2d adrenoreceptor antagonist | |||
| 0.14 | 0.12 | 0.14 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.061 | 0.041 | 0.061 | TRPA1 antagonist | |||
| 0.155 | 0.137 | 0.19 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.19 0.081 CID_9785 | CID_9785 | |
| 0.059 | 0.041 | 0.065 | Ryanodine receptor antagonist | 0.065 0.026 CID_9785 | CID_9785 | |
| 0.072 | 0.054 | 0.101 | Porphobilinogen synthase inhibitor | 0.101 0.035 CID_9785 | CID_9785 | |
| 0.085 | 0.068 | 0.085 | Triose-phosphate isomerase inhibitor | 0.08 0.075 CID_9785 | ||
| 0.022 | 0.005 | 0.024 | Thyroid hormone alpha agonist | 0.024 0.005 CID_9785 | CID_9785 | |
| 0.035 | 0.019 | 0.037 | Protein kinase (CK2) beta inhibitor | 0.037 0.016 CID_9785 | CID_9785 | |
| 0.059 | 0.043 | 0.059 | Carbamoyl phosphate synthetase inhibitor | 0.055 0.048 CID_9785 | ||
| 0.036 | 0.02 | 0.036 | Glucocorticoid antagonist | 0.035 0.021 CID_9785 | ||
| 0.047 | 0.032 | 0.047 | Thymidylate synthase inhibitor | 0.045 0.035 CID_9785 | ||
| 0.018 | 0.002 | 0.018 | DNA topoisomerase III inhibitor | 0.012 0.003 CID_9785 | ||
| 0.039 | 0.025 | 0.039 | Potassium channel Kv1.1 blocker | |||
| 0.06 | 0.047 | 0.06 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.016 | 0.005 | 0.016 | DNA polymerase III polC-type inhibitor | 0.014 0.007 CID_9785 | ||
| 0.165 | 0.153 | 0.165 | Interleukin agonist | |||
| 0.059 | 0.047 | 0.059 | NMDA receptor glycine site agonist | |||
| 0.034 | 0.024 | 0.034 | Fumarate hydratase inhibitor | 0.03 0.029 CID_9785 | ||
| 0.033 | 0.024 | 0.033 | Purinergic P2Y2 antagonist | 0.031 0.028 CID_9785 | ||
| 0.039 | 0.03 | 0.039 | Nicotinic acid receptor 1 agonist | |||
| 0.056 | 0.047 | 0.056 | Phosphodiesterase 1B inhibitor | |||
| 0.03 | 0.021 | 0.03 | Prostaglandin EP3 antagonist | |||
| 0.095 | 0.086 | 0.138 | DOPA decarboxylase inhibitor | 0.138 0.029 CID_9785 | CID_9785 | |
| 0.038 | 0.029 | 0.038 | Membrane dipeptidase inhibitor | |||
| 0.081 | 0.072 | 0.081 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.026 | 0.018 | 0.045 | Thyroid hormone agonist | 0.045 0.005 CID_9785 | CID_9785 | |
| 0.064 | 0.055 | 0.064 | Glutamate (mGluR6) antagonist | |||
| 0.061 | 0.054 | 0.061 | Acetylcholine M5 receptor agonist | |||
| 0.097 | 0.09 | 0.147 | DNA polymerase I inhibitor | 0.147 0.051 CID_9785 | CID_9785 | |
| 0.063 | 0.056 | 0.063 | Glutamate (mGluR7) antagonist | |||
| 0.024 | 0.018 | 0.024 | Glutamate (mGluR1) agonist | |||
| 0.135 | 0.129 | 0.14 | ATPase inhibitor | 0.14 0.119 CID_9785 | CID_9785 | |
| 0.115 | 0.11 | 0.115 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.044 | 0.04 | 0.044 | Phosphodiesterase 6C inhibitor | |||
| 0.075 | 0.072 | 0.123 | NMDA receptor antagonist | 0.123 0.034 CID_9785 | CID_9785 | |
| 0.037 | 0.033 | 0.063 | Dopamine D5 agonist | 0.063 0.011 CID_9785 | CID_9785 | |
| 0.1 | 0.097 | 0.108 | Interleukin 8 antagonist | 0.108 0.079 CID_9785 | CID_9785 | |
| 0.043 | 0.04 | 0.043 | Phosphodiesterase 4A inhibitor | |||
| 0.097 | 0.096 | 0.097 | Microtubule formation inhibitor | |||
| 0.016 | 0.014 | 0.016 | Calcitonin gene-related peptide 1 receptor antagonist | |||
| 0.08 | 0.078 | 0.08 | Bromodomain-containing protein 2 inhibitor | |||
| 0.047 | 0.046 | 0.047 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.023 | 0.022 | 0.023 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.044 | 0.045 | 0.078 | Aldose reductase inhibitor | 0.078 0.024 CID_9785 | CID_9785 | |
| 0.145 | 0.148 | 0.161 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.161 0.13 CID_9785 | CID_9785 | |
| 0.085 | 0.088 | 0.1 | Bile acid receptor antagonist | 0.1 0.05 CID_9785 | CID_9785 | |
| 0.081 | 0.085 | 0.147 | Creatine kinase inhibitor | 0.147 0.025 CID_9785 | CID_9785 | |
| 0.128 | 0.133 | 0.137 | Heat shock protein 70 antagonist | 0.137 0.085 CID_9785 | CID_9785 | |
| 0.005 | 0.014 | 0.011 | Thyroid hormone beta agonist | 0.011 0.005 CID_9785 | CID_9785 | |
| 0.069 | 0.08 | 0.08 | Ornithine decarboxylase inhibitor | 0.08 0.068 CID_9785 | CID_9785 | |
| 0.087 | 0.098 | 0.108 | Mucolytic | 0.108 0.067 CID_9785 | CID_9785 | |
| 0.055 | 0.066 | 0.089 | Phenylalanine 4-hydroxylase inhibitor | 0.089 0.032 CID_9785 | CID_9785 | |
| 0.115 | 0.127 | 0.137 | Hexokinase inhibitor | 0.137 0.095 CID_9785 | CID_9785 | |
| 0.192 | 0.204 | 0.25 | Interleukin 2 agonist | 0.25 0.118 CID_9785 | CID_9785 | |
| 0.063 | 0.077 | 0.077 | GABA aminotransferase inhibitor | 0.077 0.05 CID_9785 | CID_9785 | |
| 0.12 | 0.135 | 0.145 | Interferon gamma antagonist | 0.145 0.084 CID_9785 | CID_9785 | |
| 0.081 | 0.102 | 0.17 | Estrogen receptor beta antagonist | 0.17 0.013 CID_9785 | CID_9785 | |
| 0.089 | 0.111 | 0.101 | TRPA1 agonist | 0.101 0.086 CID_9785 | CID_9785 | |
| 0.051 | 0.074 | 0.093 | NMDA 2 receptor antagonist | 0.093 0.035 CID_9785 | CID_9785 | |
| 0.055 | 0.079 | 0.082 | Glutamate decarboxylase inhibitor | 0.082 0.042 CID_9785 | CID_9785 | |
| 0.105 | 0.13 | 0.12 | Vanilloid 1 agonist | 0.12 0.087 CID_9785 | CID_9785 | |
| 0.108 | 0.135 | 0.118 | Sigma receptor agonist | 0.118 0.117 CID_9785 | CID_9785 | |
| 0.129 | 0.158 | 0.152 | Phospholipase C inhibitor | 0.152 0.101 CID_9785 | CID_9785 | |
| 0.047 | 0.078 | 0.072 | Lipase inhibitor | 0.072 0.052 CID_9785 | CID_9785 | |
| 0.026 | 0.058 | 0.038 | Oxytocin agonist | 0.038 0.034 CID_9785 | CID_9785 | |
| 0.011 | 0.046 | 0.123 | Estrogen receptor beta agonist | 0.123 0.009 CID_9785 | CID_9785 | |
| 0.063 | 0.099 | 0.109 | Opioid antagonist | 0.109 0.042 CID_9785 | CID_9785 | |
| 0.074 | 0.112 | 0.118 | Xanthine oxidase inhibitor | 0.118 0.048 CID_9785 | CID_9785 | |
| 0.009 | 0.051 | 0.09 | Estrogen receptor alpha agonist | 0.09 0.01 CID_9785 | CID_9785 | |
| 0.046 | 0.088 | 0.083 | Histidine decarboxylase inhibitor | 0.083 0.041 CID_9785 | CID_9785 | |
| 0.045 | 0.089 | 0.068 | Beta adrenoreceptor antagonist | 0.068 0.041 CID_9785 | CID_9785 | |
| 0.052 | 0.096 | 0.064 | Beta 2 adrenoreceptor agonist | 0.064 0.036 CID_9785 | CID_9785 | |
| 0.059 | 0.103 | 0.095 | Opioid kappa receptor antagonist | 0.095 0.04 CID_9785 | CID_9785 | |
| 0.039 | 0.087 | 0.087 | Opioid mu receptor antagonist | 0.087 0.037 CID_9785 | CID_9785 | |
| 0.047 | 0.1 | 0.08 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.08 0.051 CID_9785 | CID_9785 | |
| 0.034 | 0.089 | 0.059 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.059 0.031 CID_9785 | CID_9785 | |
| 0.104 | 0.174 | 0.149 | Melanin inhibitor | 0.149 0.083 CID_9785 | CID_9785 | |
| 0.046 | 0.117 | 0.06 | Beta 3 adrenoreceptor antagonist | 0.06 0.056 CID_9785 | CID_9785 | |
| 0.064 | 0.138 | 0.08 | D-Ala-D-Ala ligase inhibitor | 0.08 0.069 CID_9785 | CID_9785 | |
| 0.041 | 0.119 | 0.054 | Adenine nucleotide translocase inhibitor | 0.054 0.043 CID_9785 | CID_9785 | |
| 0.076 | 0.156 | 0.105 | Aldehyde dehydrogenase inhibitor | 0.105 0.09 CID_9785 | CID_9785 | |
| 0.077 | 0.162 | 0.168 | Estrogen antagonist | 0.168 0.018 CID_9785 | CID_9785 | |
| 0.062 | 0.15 | 0.151 | M18 aspartyl aminopeptidase inhibitor | 0.151 0.051 CID_9785 | CID_9785 | |
| 0.194 | 0.284 | 0.261 | Cyclophilin D inhibitor | 0.261 0.2 CID_9785 | CID_9785 | |
| 0.142 | 0.234 | 0.208 | Hypoxia-inducible factor 1 alpha inhibitor | 0.208 0.143 CID_9785 | CID_9785 | |
| 0.094 | 0.19 | 0.122 | Papain-like protease (SARS coronavirus) inhibitor | 0.122 0.077 CID_9785 | CID_9785 | |
| 0.057 | 0.157 | 0.077 | MAP kinase kinase 7 inhibitor | 0.077 0.056 CID_9785 | CID_9785 | |
| 0.044 | 0.145 | 0.077 | Adrenaline agonist | 0.077 0.062 CID_9785 | CID_9785 | |
| 0.039 | 0.142 | 0.07 | Analgesic, opioid | 0.07 0.062 CID_9785 | CID_9785 | |
| 0.155 | 0.259 | 0.292 | Sodium/bile acid cotransporter inhibitor | 0.292 0.087 CID_9785 | CID_9785 | |
| 0.01 | 0.129 | 0.084 | Estrogen agonist | 0.084 0.022 CID_9785 | CID_9785 | |
| 0.05 | 0.17 | 0.075 | Estrogen receptor alpha antagonist | 0.075 0.057 CID_9785 | CID_9785 | |
| 0.058 | 0.179 | 0.105 | Amylase inhibitor | 0.105 0.092 CID_9785 | CID_9785 | |
| 0.038 | 0.169 | 0.101 | Monophenol monooxygenase inhibitor | 0.101 0.075 CID_9785 | CID_9785 | |
| 0.138 | 0.303 | 0.214 | Apoptosis antagonist | 0.214 0.162 CID_9785 | CID_9785 | |
| 0.072 | 0.272 | 0.13 | NOS3 expression enhancer | 0.13 0.097 CID_9785 | CID_9785 | |
| 0.047 | 0.356 | 0.117 | Interleukin 4 antagonist | 0.117 0.089 CID_9785 | CID_9785 | |
| 0.045 | 0.371 | 0.117 | Farnesoid X receptor antagonist | 0.117 0.112 CID_9785 | CID_9785 | |
| 0.01 | 0.407 | 0.03 | Estrogen-related receptor beta antagonist | 0.03 0.028 CID_9785 | CID_9785 | |
| 0.043 | 0.454 | 0.194 | Antioxidant | 0.194 0.118 CID_9785 | CID_9785 | |
| 0.021 | 0.559 | 0.168 | Free radical scavenger | 0.168 0.126 CID_9785 | CID_9785 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |